Decreased Mammogram Use Correlate with Adverse Social Determinants of Health
Lack of health insurance and not having a healthcare provider are two of the biggest factors that contribute to skipping a mammogram.
mammogram © okrasiuk - stock.adobe.com
Nearly 40,000 women in the United States die from breast cancer every year. Mammography has decreased breast cancer rates significantly. Even so, some women don’t get regular mammograms.
To determine which factors are the biggest barriers to mammogram access, a research team led by Jacqueline Miller, M.D., a board-certified general surgeon and captain with the U.S. Public Health Service, combed through data from the 2022 Behavioral Risk Factor Surveillance System. They focused on mammography prevalence in women ages 40-74 and categorized them by jurisdiction, age and sociodemographic factors. The results were published in the CDC’s Morbidity and Mortality Weekly Report earlier this month.
In a sample that included just over 117,000 women, Miller and her team found that the proportion of mammogram use increased with age. In women ages 40-49, 59.1% had gotten a mammogram every two years. In women ages 50-74, that rate was 76.5%. Black women reported the highest rates of mammography in both age ranges at 65.2% and 82.9%.
Mammography use was lowest in women without health insurance (32.7% in women ages 40-49 and 37.4% in women ages 50-74) and those who did not have a healthcare provider (32.7% and 42.2%).
In women with health insurance, rates for each age group were at 58.7% and 73.9%. For women with a healthcare provider, rates were at 63.4% and 79.1%.
To combat these issues, the White House has released a social determinants of health playbook that, among other things, calls for calls for community funding and emphasizes a greater need for social services. Mammograms are also available at a low cost or no cost through insurance mandates under the Affordable Care Act, Medicare and the CDC’s National Breast and Cervical Cancer Early Detection Program.
In 2024, CMS also issued a new billing code that allows healthcare providers to be reimbursed for performing a social determinant of health analysis on patients.
How Financial Toxicity Screening Can Be Incorporated Into Everyday Healthcare in America
November 15th 2024Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can also happen in generalized healthcare, according to Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Breast Cancer Patients Desire Early, Frequent Financial Screening
November 11th 2024Current financial screening procedures in the United States may need to change, according to recent research done by Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Patient Advocacy Groups and Caretaker Diversity in Metastatic Breast Cancer Research
October 22nd 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, shares the reasons why she chose to study metastatic breast cancer patients.
Read More
Differences in Defining 'Clinically Meaningful' in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More
